DVCR unveils a 5,000‑sq ft administration facility in Overland Park, reinforcing its commitment to people, infrastructure and innovation in early-phase clinical trials.
Highlights:
New 5,000 sq ft Building: Dr. Vince Clinical Research has opened a state-of-the-art administration facility at its Overland Park, Kansas campus, marking a major physical expansion.
People-Centric Investment: The project reflects a strategic focus on operational excellence and company culture through dedicated investment in team infrastructure.
Accelerating Innovation: DVCR seeks to enhance early-phase trial efficiency and scale its global footprint with expanded infrastructure and enhanced staff capabilities.
Summary:
Dr. Vince Clinical Research (DVCR), a leading CRO specializing in early-phase clinical trials, has inaugurated a new 5,000‑square-foot administration building on its research campus in Overland Park, Kansas. The expansion underscores DVCR’s deep investment in its people, infrastructure, and innovation, aiming to support operational excellence and a thriving team environment.
Approved by the Overland Park Planning Commission in March 2024, construction was completed within a year and positions DVCR to better serve its growing global clientele. This development marks a pivotal milestone in the company’s rapid growth and commitment to advancing clinical research infrastructure.
